Live Breaking News & Updates on Oxeza

Stay updated with breaking news from Oxeza. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Harrow buys four FDA-approved brands for $14M

Commercial rights will help company expand surgical, acute offerings ....

Mark Baum , Harrow Health , Drug Administration Approved , Food And Drug Administration , Health Sciences , Harrow Health , Orphan Drugs , Breakthrough Therapy , Health Care , Combination Drugs , Antineoplastic Drugs , Monoclonal Antibodies ,